Related Experiment Video
Updated: Mar 17, 2026
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Viral and mycoplasmal pneumonias
Henry H Balfour1, Barbara A Burke1
1a University of Minnesota Medical School Minneapolis.
Nonbacterial pneumonias can stem from various agents, often presenting similar clinical signs. Understanding their causes and spread is key for diagnosis and prevention, with specific antiviral therapies on the horizon.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Pulmonology
Background:
- Nonbacterial pneumonias are caused by a diverse range of infectious agents.
- Clinical presentation of these pneumonias can be indistinguishable, complicating diagnosis.
- Current management primarily focuses on symptomatic relief.
Purpose of the Study:
- To highlight the importance of understanding the epidemiology and pathogenesis of nonbacterial pneumonias.
- To discuss the variety of etiologic agents responsible for these infections.
- To inform about the evolving landscape of specific therapeutic interventions.
Main Methods:
- Review of existing literature on nonbacterial pneumonia.
- Analysis of etiological factors and disease mechanisms.
- Epidemiological data interpretation.
Main Results:
- A wide array of agents can cause nonbacterial pneumonia.
- Clinical manifestations lack specificity across different causative agents.
- Knowledge of epidemiology and pathogenesis aids in clinical decision-making.
Conclusions:
- Understanding the causative agents and disease processes is crucial for managing nonbacterial pneumonias.
- While symptomatic treatment is current standard, targeted antiviral therapies are anticipated.
- Further research into specific etiologies will improve diagnostic accuracy and treatment efficacy.
More Related Videos
06:04Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
01:30Pneumonia III: Complications and Assessment
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...